Breast cancer progression and aggression has been associated with stroma stiffening and it has been shown that the more aggressive basal-like and HER2 tumor subtypes are stiffer than ER-positive breast tumors, which have a better prognosis [55]. This evidence concerns the gene ERBB2 and breast cancer.